This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001
CS-003
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Decipher Genomic Classifier
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SNMMI 2024
AMA 2024
ASCO 2024
AUA 2024
APCCC 2024
All Conferences
View All
PCF
UroToday Home
Newsletter Archive
GU Onc Daily
Go
Reset
Send Date
Subject
Created Date
ID
Asc
Desc
UroAlert - GU Oncology Daily
Sent on 23 July 2024
Receive via e-mail
Navigating Non-Metastatic Castration-Resistant Prostate Cancer Treatment in the PSMA PET Era
Sent on 23 July 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 22 July 2024
Receive via e-mail
Practical Approach to Genetic Testing and Treatment Selection in Prostate Cancer
Sent on 22 July 2024
Receive via e-mail
Combination Treatment in Metastatic Hormone-Sensitive Prostate Cancer
Sent on 20 July 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 19 July 2024
Receive via e-mail
Exploring Burnout in Healthcare - The Prescription for Provider Burnout
Sent on 19 July 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 18 July 2024
Receive via e-mail
Finding the Right Patient for Lutetium-177 PSMA Treatment
Sent on 18 July 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 17 July 2024
Receive via e-mail
Advances in Bladder Cancer Treatments 2024 - Across the Spectrum from NMIBC to MIBC
Sent on 17 July 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 16 July 2024
Receive via e-mail
The Treatment Landscape for High-Risk BCR and Strategies for Personalize Treatment in mHSPC
Sent on 16 July 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 15 July 2024
Receive via e-mail
Integrating Genetic Variants and Clinical Factors for Enhanced Prostate Cancer Prognostication
Sent on 15 July 2024
Receive via e-mail
Treatment Strategies for High-Risk Localized Prostate Cancer
Sent on 13 July 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 12 July 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 11 July 2024
Receive via e-mail
Racial Differences in Bladder Cancer Detection
Sent on 11 July 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 10 July 2024
Receive via e-mail
Advances in Metastatic Prostate Cancer Treatments - News and Noteworthy First Half 2024
Sent on 10 July 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 09 July 2024
Receive via e-mail
Innovative Trials and Breakthroughs in Urothelial Carcinoma Treatment
Sent on 09 July 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 08 July 2024
Receive via e-mail
Advancements in PSMA-Based Treatments in Metastatic Castrate-Resistant Prostate Cancer
Sent on 08 July 2024
Receive via e-mail
The Intersection of Climate Change and Cancer
Sent on 06 July 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 05 July 2024
Receive via e-mail
Risk Stratification for NCCN Guidelines for Low, Intermediate, and High-Risk Prostate Cancer
Sent on 05 July 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 04 July 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 03 July 2024
Receive via e-mail
Advanced Urothelial Cancer - Current Landscape and Future Directions
Sent on 03 July 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 02 July 2024
Receive via e-mail
PSMA Ligands for Prostate Cancer Imaging
Sent on 02 July 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 01 July 2024
Receive via e-mail
Mental Health and Survivorship Across the Genitourinary Oncology Disease Spectrum
Sent on 01 July 2024
Receive via e-mail
Approaches to Improving Prostate Cancer Treatment Outcomes Across the Continuum of Disease Stages
Sent on 29 June 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 28 June 2024
Receive via e-mail
Leveraging Biomarkers in Diagnostic and Treatment Decision Making in Bladder Cancer
Sent on 28 June 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 27 June 2024
Receive via e-mail
Targeted Treatments in Advanced Prostate Cancer
Sent on 27 June 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 26 June 2024
Receive via e-mail
Bladder Preservation and Alternatives to Cystectomy for Non-Muscle Invasive Bladder Cancer
Sent on 26 June 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 25 June 2024
Receive via e-mail
Operationalizing PSMA Radioligand Therapy in Metastatic Castration-resistant Prostate Cancer Patients
Sent on 25 June 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 24 June 2024
Receive via e-mail
Current Treatments and Future Targets for the Treatment of Metastatic Castrate-Resistant Prostate Cancer
Sent on 24 June 2024
Receive via e-mail
Advanced Imaging and Androgen Receptor Pathway Inhibitors in Managing Biochemical Recurrent Prostate Cancer
Sent on 22 June 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 21 June 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 20 June 2024
Receive via e-mail
Prognostic Power of Multi-Modal Artificial Intelligence Biomarker in CHAARTED Trial
Sent on 20 June 2024
Receive via e-mail
Page
of 97
Display #
5
10
15
20
25
30
50
100
Results 1 - 50 out of 4805
Send the selected Newsletters to...
Name
E-mail
Send
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free
